The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

Journal of Neuroimmunology

Volumn 167, Issue 1-2, 2005, Pages 131-137

  Lolli, Francesco ^a   Mazzanti, Benedetta ^a   Pazzagli, Marta ^b   Peroni, Elisa ^a   Alcaro, Maria Claudia ^a   Sabatino, Giuseppina ^a   Lanzillo, Roberta ^c   Morra, Vincenzo Brescia ^c   Santoro, Lucio ^c   Gasperini, Claudio ^d   Galgani, Stefania ^d   D'Elios, Mario Milco ^a   Zipoli, Valentina ^a   Sotgiu, Stefano ^e   Pugliatti, Maura ^e   Rovero, Paolo ^a   Chelli, Mario ^a   Papini, Anna Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CSF srl   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

Autoimmunity; B cell; Diagnosis; Glycosylated antigen; Multiple sclerosis; Myelin autoantibodies

Indexed keywords

GLYCOPEPTIDE; GLYCOPEPTIDE CSF114(GLC); IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE MARKER; ENCEPHALITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 24144443537     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.05.016     Document Type: Article

References (42)

1. L. Almeras, D. Lefranc, H. Drobecq, J. De Seze, S. Dubucquoi, P. Vermersch, and L. Prin New antigenic candidates in multiple sclerosis: identification by serological proteome analysis Proteomics 4 2004 2184 2194
2. T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event N. Engl. J. Med. 349 2003 139 145
3. B. Bielekova, and R. Martin Development of biomarkers in multiple sclerosis Brain 127 2004 1463 1478
4. A. Carotenuto, A.M. D'Ursi, E. Nardi, A.M. Papini, and P. Rovero Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis J. Med. Chem. 44 2001 2378 2381
5. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231
6. L. Craig, P.C. Sanschagrin, A. Rozek, S. Lackie, L.A. Kuhn, and J.K. Scott The role of structure in antibody cross-reactivity between peptides and folded proteins J. Mol. Biol. 281 1998 183 201
7. A.H. Cross, J.L. Trotter, and J. Lyons B cells and antibodies in CNS demyelinating disease J. Neuroimmunol. 112 2001 1 14
8. P.J. Delves The role of glycosylation in autoimmune disease Autoimmunity 27 1998 239 253
9. P. Dharmasaroja Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis J. Neurol. Sci. 206 2003 7 16
10. H.A. Doyle, and M.J. Mamula Post-translational protein modifications in antigen recognition and autoimmunity Trends Immunol. 22 2001 443 449
11. R. Egg, M. Reindl, F. Deisenhammer, C. Linington, and T. Berger Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis Mult. Scler. 7 2001 285 289
12. F. Fazekas, F. Barkhof, M. Filippi, R.I. Grossman, D.K. Li, W.I. McDonald, H.F. McFarland, D.W. Paty, J.H. Simon, J.S. Wolinsky, and D.H. Miller The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology 53 1999 448 456
13. A. Garcia-Merino, M.A. Persson, J. Ernerudh, J.J. Diaz-Gil, and T. Olsson Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis J. Neurol. Neurosurg. Psychiatry 49 1986 1066 1070
14. P. Glynn, and C. Linington Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system Crit. Rev. Neurobiol. 4 1989 367 385
15. J.D. Habbema, R. Eijkemans, J. Krijnen, and J.E. Knottnerus Analysis of data on the accuracy of diagnostic tests J.E. Knottnerus The Evidence Base of Clinical Diagnosis. London 2002 BMJ Books London 117 143
16. L.E. Hughes, P.A. Smith, S. Bonell, R.S. Natt, C. Wilson, T. Rashid, S. Amor, E.J. Thompson, J. Croker, and A. Ebringer Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis J. Neuroimmunol. 144 2003 105 115
17. A. Karni, R. Bakimer-Kleiner, O. Abramsky, and A. Ben-Nun Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis Arch. Neurol. 56 1999 311 315
18. B. Kornek, and H. Lassmann Neuropathology of multiple sclerosis-new concepts Brain Res. Bull. 61 2003 321 326
19. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
20. V. Lampasona, D. Franciotta, R. Furlan, S. Zanaboni, R. Fazio, E. Bonifacio, G. Comi, and G. Martino Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects Neurology 62 2004 2092 2094
21. H. Lassmann Mechanisms of demyelination and tissue destruction in multiple sclerosis Clin. Neurol. Neurosurg. 104 2002 168 171
22. H. Lassmann, W. Bruck, and C. Lucchinetti Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy Trends Mol. Med. 7 2001 115 121
23. R.B. Lindert, C.G. Haase, U. Brehm, C. Linington, H. Wekerle, and R. Hohlfeld Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein Brain 122 1999 2089 2100
24. C. Linington, M. Bradl, H. Lassmann, C. Brunner, and K. Vass Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein Am. J. Pathol. 130 1988 443 454
25. H. Link, E. Norrby, and J.E. Olsson Immunoglobulins and measles antibodies in optic neuritis N. Engl. J. Med. 289 1973 1103 1107
26. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 1996 907 911
27. R. Mantegazza, P. Cristaldini, P. Bernasconi, F. Baggi, R. Pedotti, I. Piccini, N. Mascoli, L.L. Mantia, C. Antozzi, O. Simoncini, F. Cornelio, and C. Milanese Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association Int. Immunol. 16 2004 559 565
28. E. Mathey, C. Breithaupt, A.S. Schubart, and C. Linington Commentary: sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire Eur. J. Immunol. 34 2004 2065 2071
29. T. Mathiesen, H. von Holst, S. Fredrikson, G. Wirsen, B. Hederstedt, E. Norrby, V.A. Sundqvist, and B. Wahren Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system J. Neurol. 236 1989 238 242
30. M.K. Matyszak Inflammation in the CNS: balance between immunological privilege and immune responses Prog. Neurobiol. 56 1998 19 35
31. S. Mazzucco, S. Mata, M. Vergelli, R. Fioresi, E. Nardi, B. Mazzanti, M. Chelli, F. Lolli, M. Ginanneschi, F. Pinto, L. Massacesi, and A.M. Papini A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases Bioorg. Med. Chem. Lett. 9 1999 167 172
32. A.M. Papini, B. Mulinacci, E. Peroni, G. Sabatino, M. Chelli, A. Carotenuto, P. Rovero, and F. Lolli CSF114(Glc): the glycopeptide detecting autoantibodies in multiple sclerosis. PepKit, the first diagnostic test to follow-up the disease activity E. Benedetti C. Pedone Peptides 2002, Proceedings of the European Peptide Symposium 2002 998 999
33. Papini, A.M., Chelli, M., Rovero, P., Lolli, F. inventors, 2003. Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis. Italy. International Patent Application 2003, number WO 03/000733 A2.
34. M.A. Persson, M.A. Laurenzi, and D. Vranjesevic Extended repertoire of specific antibodies in CSF of patients with subacute sclerosing panencephalitis compared to those with multiple sclerosis: anti-bacterial antibodies are also increased J. Neuroimmunol. 22 1989 135 142
35. C.M. Poser, D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, G.C. Ebers, K.P. Johnson, W.A. Sibley, D.H. Silberberg, and W.W. Tourtellotte New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann. Neurol. 13 1983 227 231
36. H. Reiber, and P. Lange Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain Clin. Chem. 37 1991 1153 1160
37. J. Rosenbluth, R. Schiff, W.L. Liang, and W. Dou Antibody-mediated CNS demyelination: II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma J. Neurocytol. 32 2003 265 276
38. I.A. Schrijver, M. van Meurs, M.J. Melief, C. Wim Ang, D. Buljevac, R. Ravid, M.P. Hazenberg, and J.D. Laman Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis Brain 124 2001 1544 1554
39. B. Vandvik, J.B. Natvig, and D. Wiger IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides Scand. J. Immunol. 5 1976 427 436
40. F. Vartdal, B. Vandvik, and E. Norrby Viral and bacterial antibody responses in multiple. Sclerosis Ann. Neurol. 8 1980 248 255
41. G.R. Wayne Moore MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? J. Neurol. Sci. 206 2003 175 179
42. N. Yuki, K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome Proc. Natl. Acad. Sci. U. S. A. 101 2004 11404 11409